ES2158094T3 - Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzazepina. - Google Patents

Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzazepina.

Info

Publication number
ES2158094T3
ES2158094T3 ES95912143T ES95912143T ES2158094T3 ES 2158094 T3 ES2158094 T3 ES 2158094T3 ES 95912143 T ES95912143 T ES 95912143T ES 95912143 T ES95912143 T ES 95912143T ES 2158094 T3 ES2158094 T3 ES 2158094T3
Authority
ES
Spain
Prior art keywords
tetrahidro
benzazepina
addition salts
compound acid
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95912143T
Other languages
English (en)
Inventor
Louis Brammer Hansen
Rolf Emil Amsler
Scott Eugene Mcgraw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Paion UK Ltd
Original Assignee
Cenes Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cenes Ltd filed Critical Cenes Ltd
Application granted granted Critical
Publication of ES2158094T3 publication Critical patent/ES2158094T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA INVENCION SUMINISTRA UNA SERIE DE SALES CRISTALINAS DE (S)8-CLORO-5-(5-BROMO-2,3-DIHIDROBENZOFURAN-7-IL)-3-METIL-2,3,4,5TETRAHIDRO-1H-3-BENZACEPINA-7-OL, SU PREPARACION Y SU USO COMO AGENTES TERAPEUTICOS.
ES95912143T 1994-03-16 1995-03-08 Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzazepina. Expired - Lifetime ES2158094T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK31194 1994-03-16

Publications (1)

Publication Number Publication Date
ES2158094T3 true ES2158094T3 (es) 2001-09-01

Family

ID=8092128

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95912143T Expired - Lifetime ES2158094T3 (es) 1994-03-16 1995-03-08 Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzazepina.

Country Status (10)

Country Link
US (1) US5658899A (es)
EP (1) EP0750616B1 (es)
JP (1) JPH09510222A (es)
AT (1) ATE201680T1 (es)
AU (1) AU1945495A (es)
DE (1) DE69521122T2 (es)
DK (1) DK0750616T3 (es)
ES (1) ES2158094T3 (es)
IL (1) IL112999A0 (es)
WO (1) WO1995025102A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410527B1 (en) * 1998-03-02 2002-06-25 Schering Corporation Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism
DE19853487A1 (de) 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
DE10000577A1 (de) * 2000-01-10 2001-07-26 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten
CA2776023A1 (en) 2001-01-12 2002-07-18 Fumapharm Ag Fumaric acid amides
UA79248C2 (en) * 2001-11-09 2007-06-11 Janssen Pharmaceutica Nv Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
JP2005539010A (ja) * 2002-08-05 2005-12-22 サンド・アクチエンゲゼルシヤフト デスロラタジンヘミフマレートの新規な塩及び多形体
DK1663197T3 (da) 2003-09-09 2008-01-07 Fumapharm Ag Anvendelse af fumarsyrederivater til behandling af hjerteinsuffiens og astma
EP2653873B8 (en) 2007-02-08 2022-08-24 Biogen MA Inc. Compositions and uses for treating Multiple Sclerosis
WO2013040401A1 (en) * 2011-09-16 2013-03-21 Persimmon Technologies, Corp. Low variability robot
EP4616915A3 (en) 2012-07-12 2025-12-17 Emalex Biosciences, Inc. Ecopipam for treatment of tourettes syndrome
US9949983B2 (en) 2013-10-18 2018-04-24 Psyadon Pharmaceuticals, Inc. Fused benzazepines for treatment of stuttering
KR102424958B1 (ko) 2014-01-21 2022-07-25 퍼시몬 테크놀로지스 코포레이션 기판 이송 진공 플랫폼
WO2025194153A1 (en) 2024-03-15 2025-09-18 Emalex Biosciences, Inc. Pharmaceutical dosage forms and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK23392D0 (da) * 1992-02-24 1992-02-24 Novo Nordisk As Heterocykliske forbindelser, deres anvendelse og fremstilling
US5470850A (en) * 1992-02-24 1995-11-28 Novo Nordisk A/S 2,3,4,5-tetrahydro-1H-3-benzazepines

Also Published As

Publication number Publication date
DE69521122D1 (de) 2001-07-05
WO1995025102A1 (en) 1995-09-21
IL112999A0 (en) 1995-06-29
EP0750616A1 (en) 1997-01-02
ATE201680T1 (de) 2001-06-15
DK0750616T3 (da) 2001-07-23
US5658899A (en) 1997-08-19
EP0750616B1 (en) 2001-05-30
AU1945495A (en) 1995-10-03
DE69521122T2 (de) 2002-03-07
JPH09510222A (ja) 1997-10-14

Similar Documents

Publication Publication Date Title
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
ES2148486T3 (es) Intermediarios de cloropirimidina.
ES2144151T3 (es) Benzotiazepinas hipolipidemicas.
EE05074B1 (et) Sulfoonamiid- ja sulfamiidasendatud imidasokinoliinid, nende kasutamine raviks ja neid sisaldavad farmatseutilised preparaadid
ES2192708T3 (es) Combinaciones de productos activos fungicidas.
EE200000595A (et) Toimeaine viimine kandjamaatriksisse
MX9301136A (es) Composiciones que contienen psyllium.
SE9801494D0 (sv) Novel use
ATE201680T1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure- additions-salze
CO4940448A1 (es) Modificacion a cristal de una sustancia de medicamento
ES2156215T3 (es) Utilizacion de un conjugado en el tratamiento y/o diagnostico de enfermedades inflamatorias.
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
ATE28188T1 (de) Antikonvulsive mittel.
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
SE9504662D0 (sv) New compounds
ES2152315T3 (es) Xamoneline tartrato.
ES2162410T3 (es) Uso de alcohol diclorobencilico para hacer una preparacion para tratamiento topico de inflamacion.
ITMI922742A0 (it) Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
AU580890B2 (en) P-acylaminobenzamides
PT837677E (pt) Derivados hexa-hidroxibifenilo bromados
AR021616A1 (es) Cicloheptenos sustituidos, procedimiento para su preparacion y uso de los mismos.
BR9808210A (pt) Befeniloxazolinas dissubstituìdas
ES2158441T3 (es) Arilheterociclos con actividad herbicida.
ES2186909T3 (es) Agentes antipaludicos y antibabesiosis y composiciones farmaceuticas que los contienen.
EP0729950A4 (en) ANTI-HIV MEDICINAL PRODUCTS

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 750616

Country of ref document: ES